Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ulla Breth Knudsen

Showing results (1-10 of 41) with videos related to

Pageof 5
Sort By:
Ugeskrift for Laeger|June 14, 2017
Ulla Breth Knudsen
Danish Medical Journal|December 1, 2021
Complementary and alternative medicine among women and men prior to and during fertility treatmentAnne Soegaard, Ulla Breth Knudsen
Ugeskrift for Laeger|March 27, 2004
[Surgical treatment of uterine bleeding]Lisbeth Nilas, Ulla Breth Knudsen
Pregnancy Hypertension|November 21, 2017
Preeclampsia and later cardiovascular disease - What do national guidelines recommend?Gitte Bro Schmidt, Martin Christensen, Ulla Breth Knudsen
JBRA Assisted Reproduction|March 12, 2021
Embryo Culture Media Influence on Live Birth Rate and Birthweight after IVF/ICSI: A Systematic Review Comparing Vitrolife G5 Media to Other Common Culture MediaLena Bick, Anja Schulz Nielsen, Ulla Breth Knudsen
European Journal of Obstetrics, Gynecology, and Reproductive Biology|May 27, 2014
Endometriosis and type 1 allergies/immediate type hypersensitivity: a systematic reviewHelle Folge Bungum, Christian Vestergaard, Ulla Breth Knudsen
Ugeskrift for Laeger|December 2, 2021
[Oocyt donation]Elisabeth Clare Larsen, Ursula Bentin-Ley, Ulla Breth Knudsen
Acta Obstetricia Et Gynecologica Scandinavica|May 6, 2011
Excretion patterns of large and small proteins in pre-eclamptic pregnanciesCamilla Kronborg, Erik Vittinghus, Jim Allen, et al.
Acta Obstetricia Et Gynecologica Scandinavica|August 23, 2007
One or two day mifepristone-misoprostol interval for second trimester abortionLisbeth Nilas, Marianne Glavind-Kristensen, Thomas Vejborg, et al.
Acta Obstetricia Et Gynecologica Scandinavica|October 20, 2005
An outpatient regimen of combined oral mifepristone 400 mg and misoprostol 400 microg for first-trimester legal medical abortionPernille Ravn, Ase Rasmussen, Ulla Breth Knudsen, et al.
Pageof 5

Showing results (1-10 of 41) with videos related to

Sort By:
Pageof 5
Ugeskrift for Laeger|June 14, 2017
Ulla Breth Knudsen
Danish Medical Journal|December 1, 2021
Complementary and alternative medicine among women and men prior to and during fertility treatmentAnne Soegaard, Ulla Breth Knudsen
Ugeskrift for Laeger|March 27, 2004
[Surgical treatment of uterine bleeding]Lisbeth Nilas, Ulla Breth Knudsen
Pregnancy Hypertension|November 21, 2017
Preeclampsia and later cardiovascular disease - What do national guidelines recommend?Gitte Bro Schmidt, Martin Christensen, Ulla Breth Knudsen
JBRA Assisted Reproduction|March 12, 2021
Embryo Culture Media Influence on Live Birth Rate and Birthweight after IVF/ICSI: A Systematic Review Comparing Vitrolife G5 Media to Other Common Culture MediaLena Bick, Anja Schulz Nielsen, Ulla Breth Knudsen
European Journal of Obstetrics, Gynecology, and Reproductive Biology|May 27, 2014
Endometriosis and type 1 allergies/immediate type hypersensitivity: a systematic reviewHelle Folge Bungum, Christian Vestergaard, Ulla Breth Knudsen
Ugeskrift for Laeger|December 2, 2021
[Oocyt donation]Elisabeth Clare Larsen, Ursula Bentin-Ley, Ulla Breth Knudsen
Acta Obstetricia Et Gynecologica Scandinavica|May 6, 2011
Excretion patterns of large and small proteins in pre-eclamptic pregnanciesCamilla Kronborg, Erik Vittinghus, Jim Allen, et al.
Acta Obstetricia Et Gynecologica Scandinavica|August 23, 2007
One or two day mifepristone-misoprostol interval for second trimester abortionLisbeth Nilas, Marianne Glavind-Kristensen, Thomas Vejborg, et al.
Acta Obstetricia Et Gynecologica Scandinavica|October 20, 2005
An outpatient regimen of combined oral mifepristone 400 mg and misoprostol 400 microg for first-trimester legal medical abortionPernille Ravn, Ase Rasmussen, Ulla Breth Knudsen, et al.
Pageof 5